JENKINSON PAUL L 4
4 · Kite Pharma, Inc. · Filed Sep 27, 2017
Insider Transaction Report
Form 4
JENKINSON PAUL L
Chief Financial Officer
Transactions
- Award
Common Stock
2017-09-25+2,500→ 10,410 total - Sale
Common Stock
2017-09-25$179.66/sh−948$170,321→ 9,462 total
Holdings
- 3,000(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on August 18, 2017.
- [F2]The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
- [F3]The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.